Skip to main content
Andrew Wang, MD, Radiation Oncology, Dallas, TX, University of Texas Southwestern Medical Center

AndrewZhuangWangMD(He/Him)

Radiation Oncology Dallas, TX

Gastrointestinal Cancer, Urologic Cancer

A. Kenneth Pye Professor in Cancer Research Vice Chair of Translational Research and commercialization Department of Radiation Oncology UT Southwestern Medical Center

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wang's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2009
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2004 - 2005
  • Harvard Medical School
    Harvard Medical SchoolClass of 2004

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2021 - 2025
  • NC State Medical License
    NC State Medical License 2009 - 2024
  • MA State Medical License
    MA State Medical License 2006 - 2009
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Fellow American Society for Clinical Investigation, 2019
  • Fellow The American Institute for Medical and Biological Engineering (AIMBE), 2018
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Books/Book Chapters

  • Join now to see all

Lectures

  • Nanomedicine approaches to chemoradiation 
    Gordon Conference: Cancer Nanotechnology - 2013
  • Plenary speaker: Reformulating failed drugs using nanoparticles 
    National Cancer Institute Centers for Nanotechnology Excellence Principle Investigators Meeting - 2013
  • Nanomedicine to improve chemoradiotherapy 
    Dartmouth College Cancer Nanotechnology Symposium: Immuno Targeting and Delivery - 2013
  • Join now to see all

Other

  • Drug delivery system for pharmaceuticals and radiation 
    Wang AZ, Farokhzad OC, Zhang LF, Radovic-Moreno A, Gu F, Langer R.
    International PCT Patent Application No.: PCT/US08/082655
  • Delivery for brachytherapy and associated methods. 
    Wang Z, Werner M, Chen R, Byrne J, Karve S, Desimone J.
    International PCT Patent Application No.: PCT/US2010/053357
  • Novel Wortmannin Nanoparticles and Uses Thereof. 
    Wang Z, Pacold M, Werner M, Karve S.
    US PCT/US2011/ 61431689
  • Join now to see all

Press Mentions

  • UT Southwestern Develops Nanotherapeutic to Ward off Liver Cancer
    UT Southwestern Develops Nanotherapeutic to Ward off Liver CancerJanuary 14th, 2022
  • Researchers Study Strategies for Using Nanotechnology to Boost Cancer Therapeutics
    Researchers Study Strategies for Using Nanotechnology to Boost Cancer TherapeuticsApril 23rd, 2019
  • Improved Capture of Cancer Cells Could Aid in Disease Tracking
    Improved Capture of Cancer Cells Could Aid in Disease TrackingMarch 15th, 2018

Grant Support

  • Development of 3D organ-specific models of colorectal cancer metastasisNational Institutes of Health/National Cancer Institute2013–Present
  • Nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapyNational Institutes of Health/National Cancer Institute2013–Present
  • Center for Cancer Nanotechnology ExcellenceNational Institutes of Health/National Cancer Institute2010–Present
  • Development of nanoparticle formulations of DNA double-strand break repair inhibitors to improve chemoradiotherapyLung Cancer Research Foundation2012–2013
  • Development of Nanoparticle-based Multiplex Multimodality Imaging Agents for the Specific and Sensitive Detection of CancerNational Academies of Science-Keck Futures Initiative Imaging Science2011–2013
  • Multifunctional Targeted Theranostic Nanoparticles Delivering Gemcitabine Triphosphate and IndiumNational Institutes of Health2011–2012
  • Particle Loaded Spacers for Prostate Cancer BrachytherapyUniversity of North Carolina Cancer Research Fund2010–2012
  • Particle-loaded spacers for prostate cancer brachytherapyNational Institutes of Health/National Cancer Institute2010–2012
  • Development of molecularly targeted nanoparticles for the delivery of radiosensitizersTriad Golfers Against Cancer2010–2011

Research History

  • Postdoctoral FellowResearch Fellow, Robert Langer, D.Sc./Omid Farokhzad, M.D. HST/Harvard-MIT Center for Nanotechnology Excellence, Cambridge, MA2006 - 2009

Professional Memberships

Other Languages

  • Chinese (Mandarin)

Hospital Affiliations

Industry Relationships

  • Research Support, Varian2020 - Present
  • Co-Founder and Board Member, Archimmune Therapeutics2019 - Present
  • Co-founder and CEO, Capio Bioscience2014 - Present
  • Research support, Accuray2015 - 2017
  • Consultant, Cerulean Pharma2014 - 2016
  • Consultant, Samyang Biopharmaceuticals, INCEvaluate nanoparticle formulation of docetaxelDisclosure: consulting fee2011 - 2012